Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
Harborview Injury Prevention & Research Center, University of Washington, Seattle, WA.
Pediatr Crit Care Med. 2023 Feb 1;24(Supplement 1 2S):S28-S44. doi: 10.1097/PCC.0000000000003157. Epub 2023 Jan 20.
To summarize the evidence for the Second Pediatric Acute Lung Injury Consensus Conference-2 (PALICC-2) recommendations for assessment of outcomes among patients surviving pediatric acute respiratory distress syndrome (PARDS).
MEDLINE (Ovid), Embase (Elsevier), and CINAHL Complete (EBSCOhost).
We conducted a scoping review to identify studies evaluating outcomes following PARDS. We included studies of survivors of PARDS, acute respiratory failure with a high proportion of PARDS patients, or other critical illnesses if PARDS-specific outcomes could be extracted.
Title/abstract review, full-text review, and data extraction using a standardized data collection form.
The Grading of Recommendations Assessment, Development and Evaluation approach was used to identify and summarize evidence and develop recommendations. Of 8,037 abstracts screened, we identified 20 articles for inclusion. Morbidity following PARDS was common and affected multiple domains of pulmonary and nonpulmonary function. There was insufficient evidence to generate any evidence-based recommendations. We generated eight good practice statements and five research statements. A panel of 52 experts discussed each proposed good practice statement and research statement, and the agreement rate was measured with an online voting process. Good practice statements describe the approach to clinical outcome assessment, assessment of pulmonary outcomes of children surviving PARDS, and assessment of nonpulmonary outcomes of children surviving PARDS including health-related quality of life and physical, neurocognitive, emotional, family, and social functioning. The five research statements relate to assessment of patient preillness status, use of postdischarge endpoints for clinical trials, the association between short-term and longer term outcomes, the trajectory of recovery following PARDS, and practices to optimize follow-up.
There is increasing evidence that children are at risk for impairments across a range of pulmonary and nonpulmonary health domains following hospitalization for PARDS. The results of this extensive scoping review and consensus conference involving experts in PARDS research, clinical care, and outcomes assessment provide guidance to clinicians and researchers on postdischarge follow-up to optimize the long-term health of patients surviving PARDS.
总结第二届儿科急性呼吸窘迫综合征共识会议-2(PALICC-2)有关评估儿科急性呼吸窘迫综合征(PARDS)存活患者结局的建议的证据。
MEDLINE(Ovid)、Embase(Elsevier)和 CINAHL Complete(EBSCOhost)。
我们进行了范围界定审查,以确定评估 PARDS 后结局的研究。我们纳入了 PARDS 存活患者、急性呼吸衰竭且 PARDS 患者比例较高的研究,或可提取 PARDS 特定结局的其他危重病研究。
标题/摘要审查、全文审查和使用标准化数据收集表进行数据提取。
采用推荐评估、制定与评价方法(Grading of Recommendations Assessment, Development and Evaluation approach)来识别和总结证据并制定建议。在筛选的 8037 篇摘要中,我们确定了 20 篇文章纳入分析。PARDS 后发病率较高,影响了多个肺和非肺功能领域。没有足够的证据生成任何基于证据的建议。我们制定了 8 条良好实践陈述和 5 条研究陈述。一个由 52 名专家组成的小组讨论了每个拟议的良好实践陈述和研究陈述,并用在线投票过程测量了达成一致的比例。良好实践陈述描述了临床结局评估的方法、评估 PARDS 存活儿童的肺结局以及评估 PARDS 存活儿童的非肺结局,包括健康相关生活质量和身体、神经认知、情感、家庭和社会功能。这 5 条研究陈述涉及评估患者发病前状况、将出院后终点用于临床试验、短期和长期结局之间的关联、PARDS 后恢复轨迹以及优化随访的实践。
越来越多的证据表明,PARDS 住院治疗后,儿童在一系列肺和非肺健康领域存在受损风险。这项广泛的范围界定审查和共识会议的结果,涉及 PARDS 研究、临床护理和结局评估方面的专家,为临床医生和研究人员提供了有关出院后随访的指导,以优化 PARDS 存活患者的长期健康。